Bringing OSD manufacturing expertise to Contract Pharma conference, New Jersey

Ennigerloh, Germany: – World-leader in pharma production machinery, L.B. Bohle Maschinen und Verfahren GmbH, will contribute its deep expertise in advanced processes for oral solid dose (OSD) production to the 25^th Annual Contract Pharma contracting and outsourcing conference in the USA.

L.B. Bohle is a Bronze Sponsor of the conference, which is being staged in late September in New Brunswick, NJ, and will also be an exhibitor at the event.

OSD hot topics

The conference team led by Mike Fazio, Director of Sales and Marketing for L.B. Bohle LLC, will use their tabletop displays to inform visitors, prospects and customers about the latest trends and topics in pharmaceutical OSD production, with particular focus on ‘hot topic’ areas such as Tablet Coating, Dry Granulation, Container Blending and Continuous Manufacturing.

The team will also participate in the two-day conference’s various networking opportunities. They aim to show the impressive design, engineering, and workflow integration strengths that have established L.B. Bohle as a leading equipment partner for the pharma contracting and outsourcing sectors.

About L.B. Bohle

Founded in 1981, L.B. Bohle Maschinen und Verfahren GmbH (L.B. Bohle) has established a worldwide reputation as a producer and supplier of advanced systems for pharmaceutical manufacturing, based on a track record of technological innovation and continuous improvement.

Based at Ennigerloh in Northwest Germany, L.B. Bohle operates worldwide, offering advanced solutions for every aspect of oral solid dose (OSD) and nutraceutical tablet production, including weighing & dosing, grinding & sieving, blending, tablet coating, sorting, handling systems, cleaning and containment, and continuous manufacturing.

The company’s guiding vision is one of technological innovation in the production of pharmaceutical solids. This supports a core mission to deliver maximum product efficiency increases for its customers, through continuous development and product innovations that not only increase quality and efficiency but also strengthen competitive edge and sustainability.

To these ends, L.B. Bohle offers both complete production lines and solutions for individual production steps, focusing on rapid development and production of sophisticated, pragmatic, and customized applications.

The company operates development and manufacturing facilities at its home base at Ennigerloh and at Sassenberg, both in North Rhine-Westphalia. Additionally, it has sales and service subsidiaries in the USA (Warminster, PA) in India (Ahmedabad), and Switzerland (Reiden). It is also represented by more than 40 qualified sales partners worldwide, having become a globally recognized brand.

Further information at: www.lbbohle.com  and www.continuous-manufacturing.com

About Contract Pharma 2026

First staged in 2001, the Contract Pharma Conference provides an annual forum for the pharma contracting and outsourcing industries.

Contract Pharma 2026 is a two-day event opening September 24 at the Hyatt Regency Hotel in New Brunswick, New Jersey, featuring a Tabletop Exhibition on its first day.

Organizers are hoping to exceed the success of last year’s conference, which featuring record attendance, a sold-out exhibit hall with 154 contract service providers, and an impressive lineup of speakers and sessions focused on the most pressing issues facing the industry.

Topics on the agenda for the 25^th anniversary conference include a review of the development of contracting over the period, the challenges of scaling manufacturing for advanced therapies, an FDA regulatory update, and the cost, capability and capacity factors in CDMO selection.

The event is organized by Rodman Media’s Contract Pharma magazine, with further information at: https://conference.contractpharma.com/

Resources

Connect with L.B. Bohle through its Events & Exhibitions home page.
Visit Bohle  Technology Center and Service Center virtually in a 360° tour.